First Horizon Advisors, Inc. Karuna Therapeutics, Inc. Transaction History

First Horizon Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 03, 2023	BUY	$176.32 - $240.22 $1,939 - $2,642	11 Added 7.28%	162 $35,000
Q1 2023 May 15, 2023	BUY	$161.33 - $204.36 $8,873 - $11,239	55 Added 57.29%	151 $27,000
Q4 2022 Feb 10, 2023	BUY	$191.53 - $236.82 $4,979 - $6,157	26 Added 37.14%	96 $18,000
Q3 2022 Nov 09, 2022	BUY	$123.79 - $277.42 $8,665 - $19,419	70 New	70 $14,000

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on First Horizon Advisors, Inc. with notifications on news.